Extract

This study is to test the efficacy and safety of PHX1149T in combination with metformin, a glitazone, or metformin and a glitazone in subjects with Type 2 diabetes for 12 weeks. After completing the 12 week double blind part of the study, subjects can enter an open label extension study

Inclusion criteria

• Type 2 diabetes mellitus

Country

• Argentina
• Canada
• India
• Mexico
• United States

Links

• ictrp
• nct